You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ArQule

Showing 1 - 25 of 38
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in Italy, United States (Derazantinib low dose range, Derazantinib middle dose range, Derazantinib high dose

Completed
Has Results
  • Solid Tumor
  • Derazantinib low dose range
  • +3 more
  • Scottsdale, Arizona
  • +11 more
Mar 7, 2022

Solid Tumors Trial in Dallas (ARQ 761, ARQ 761 Weekly Administration, Bi-Weekly Administration of ARQ 761)

Completed
  • Solid Tumors
  • ARQ 761
  • +3 more
  • Dallas, Texas
    UT Southwestern Medical Center - Simmons Cancer Center
Mar 13, 2020

Hepatocellular Carcinoma Trial in Worldwide (Tivantinib, Placebo)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Tucson, Arizona
  • +112 more
Mar 12, 2021

PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome Trial in Worldwide (Miransertib)

Terminated
  • PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome
  • Atlanta, Georgia
  • +10 more
May 10, 2022

Proteus Syndrome, PIK3CA-Related Overgrowth Spectrum (PROS), Growth Disorders Trial (ARQ 092)

No longer available
  • Proteus Syndrome
  • +2 more
  • ARQ 092
  • (no location specified)
Jul 31, 2021

Proteus Syndrome Trial run by the NHGRI (MK-7075 (miransertib))

Completed
  • Proteus Syndrome
  • MK-7075 (miransertib)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 29, 2022

Proteus Syndrome Trial run by the NHGRI (MK-7075 (miransertib))

Recruiting
  • Proteus Syndrome
  • MK-7075 (miransertib)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 19, 2022

Advanced Solid Tumors Trial (Tivantinib, Anti-Cancer Combination Therapy)

Completed
Has Results
  • Advanced Solid Tumors
  • (no location specified)
Feb 17, 2021

Solid Tumors Trial in United States (Tivantinib (ARQ 197) Capsule, Tivantinib (ARQ 197) Tablet, Tivantinib (ARQ 197) Capsule D,

Completed
  • Solid Tumors
  • Tivantinib (ARQ 197) Capsule
  • +2 more
  • Santa Monica, California
  • +3 more
Feb 8, 2019

Solid Tumors, Ovarian Cancer, Endometrial Cancer Trial in United States (ARQ 092 + carboplatin + paclitaxel (Closed), ARQ 092 +

Terminated
  • Solid Tumors
  • +2 more
  • ARQ 092 + carboplatin + paclitaxel (Closed)
  • +2 more
  • Grand Rapids, Michigan
  • +4 more
Sep 28, 2020

Non Squamous, Non-small-cell Lung Cancer Trial in Worldwide (Tivantinib, Placebo, Erlotinib)

Terminated
Has Results
  • Non Squamous, Non-small-cell Lung Cancer
  • Tucson, Arizona
  • +304 more
Mar 12, 2021

Cancer, Solid Tumors Trial in United States (Vevorisertib, Fulvestrant, Paclitaxel)

Terminated
Has Results
  • Cancer
  • Solid Tumors
  • Las Vegas, Nevada
  • +5 more
Jun 14, 2022

Solid Tumor, Malignant Lymphoma, Tumor Trial in United States (ARQ 092)

Completed
  • Solid Tumor
  • +2 more
  • ARQ 092
  • Birmingham, Alabama
  • +6 more
Oct 19, 2017

Metastatic NSCLC Trial in United States (ARQ 197 plus erlotinib, Pemetrexed, docetaxel or gemcitabine)

Completed
Has Results
  • Metastatic Non-Small Cell Lung Cancer
  • ARQ 197 plus erlotinib
  • Pemetrexed, docetaxel or gemcitabine
  • Stanford, California
  • +12 more
Mar 5, 2018

Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed

Completed
  • Intrahepatic Cholangiocarcinoma
  • +2 more
    • Atlanta, Georgia
    • +5 more
    Jun 7, 2017

    Cancer Trial in Santa Monica, Boston, Dallas (ARQ 171)

    Terminated
    • Cancer
    • ARQ 171
    • Santa Monica, California
    • +2 more
    Mar 2, 2017

    Advanced Solid Tumors Trial in Italy, United States (Treatment with ARQ 197 in combination with sorafenib)

    Completed
    • Advanced Solid Tumors
    • Treatment with ARQ 197 in combination with sorafenib
    • Boston, Massachusetts
    • +3 more
    Jan 23, 2014

    Gastric Cancer Trial (ARQ 197, Oxaliplatin, capecitabine or irinotecan)

    Withdrawn
    • Gastric Cancer
    • ARQ 197
    • Oxaliplatin, capecitabine or irinotecan
    • (no location specified)
    Jan 6, 2014

    Solid Tumor Trial in Italy, United States (ARQ 736)

    Completed
    • Solid Tumor
    • ARQ 736
    • Los Angeles, California
    • +3 more
    May 2, 2013

    Cancer Trial in Dallas (ARQ 501)

    Completed
    • Cancer
    • ARQ 501
    • Dallas, Texas
      Mary Crowley Medical Research Center
    Feb 22, 2013

    Non Small Cell Lung Cancer Trial in Worldwide (ARQ 197, Erlotinib, Placebo)

    Completed
    • Non Small Cell Lung Cancer
    • ARQ 197
    • +2 more
    • Burbank, California
    • +37 more
    Feb 22, 2013

    Unresectable Hepatocellular Carcinoma Trial in Worldwide (ARQ 197, Placebo)

    Completed
    • Unresectable Hepatocellular Carcinoma
    • ARQ 197
    • Placebo
    • Los Angeles, California
    • +22 more
    Feb 22, 2013

    Renal Cell Carcinoma (RCC), Alveolar Soft Part Sarcoma (ASPS), Clear Cell Sarcoma (CCS) Trial in Canada, United Kingdom, United

    Completed
    • Renal Cell Carcinoma (RCC)
    • +2 more
    • ARQ 197
    • San Francisco, California
    • +8 more
    Feb 6, 2013

    Pancreatic Tumors Trial in Poland (ARQ 197, gemcitabine)

    Completed
    • Pancreatic Neoplasms
    • Krakow, Poland
    • +5 more
    Feb 21, 2013

    Cancer Trial in Encinitas, Santa Monica (ARQ 197)

    Completed
    • Cancer
    • ARQ 197
    • Encinitas, California
    • +1 more
    Jul 20, 2012